This study is looking at whether a new way of programming the Enterra® Therapy System can better help people with gastroparesis (a condition where your stomach empties too slowly). The Enterra® Therapy System is a device that uses mild electrical pulses to help with severe nausea and vomiting. Researchers want to see if this enhanced programming improves symptoms faster and boosts your quality of life. You could join if you are 18 to 70 years old and have been diagnosed with gastroparesis. The study will measure success by looking at how often you vomit and how severe your nausea is after three months. The current status of this study is unclear, so it's not known if they are actively enrolling participants.

Study design

This is an interventional study planning to enroll 50 participants. Participants will be randomly assigned to one of two programming strategies after receiving the Enterra® Therapy System implant.

What's involved

You will answer daily questions about your symptoms using a phone/tablet app and complete quality of life questionnaires at monthly study visits. Your involvement will last up to six months after treatment assignment.

Compensation

Not stated in the trial record.

Follow-up

Your vomiting frequency and nausea severity will be measured at 3 months, and you will be involved in the study for up to six months after treatment assignment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.